Literature DB >> 12467064

Elevated focal adhesion kinase expression facilitates oral tumor cell invasion.

Galen B Schneider1, Zoya Kurago, Rebecca Zaharias, Lynn M Gruman, Michael D Schaller, Mary J C Hendrix.   

Abstract

BACKGROUND: Understanding the molecular mechanisms of metastasis is critical with respect to oral tumorigenesis. The focal adhesion kinase (FAK) is an intracellular tyrosine kinase associated with the regulation of cell growth, migration, and survival. The purpose of the current study was to determine whether elevated FAK expression in oral malignancies was associated with increased invasiveness and oral carcinoma.
METHODS: Immunohistochemical analysis was used to assess levels of FAK expression in archived oral carcinoma tissue samples. Invasion assays after transfections were used to assess the effect of increased FAK expression on invasive potential of oral tumor cells.
RESULTS: The human oral carcinoma cell line SCC25 was significantly more invasive (P < 0.05) and expressed higher levels of FAK compared with the less invasive human oral carcinoma cell line SCC15. FAK expression was 3.0-fold higher in the SCC15 cell line and 5.0-fold higher in the SCC25 cell line compared with normal epithelial cells. In the highly invasive SCC25 cell line, FAK expression was 1.5-fold higher compared with the less invasive SCC15 cell line. FAK immunostaining in oral tumors was significantly more intense compared with the immunostaining in surrounding normal epithelium or chronic mucositis. Overexpression of FAK in low-invading SCC15 cells resulted in a 4.5-fold increase in the rate of invasion compared with untransfected or neotransfected control SCC15 cell lines and a nearly 1.5-fold greater rate compared with the highly invasive untransfected SCC25 cell line.
CONCLUSIONS: The current results suggest that enhanced expression of FAK in oral carcinoma cells may lead to a selective growth advantage and increased invasive potential of the primary oral tumor. Copyright 2002 American Cancer Society.DOI 10.1002/cncr.10992

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467064     DOI: 10.1002/cncr.10992

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  22 in total

Review 1.  Integrin signaling and mammary cell function.

Authors:  Franziska Schatzmann; Rebecca Marlow; Charles H Streuli
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

2.  Focal adhesion kinase is activated in invading fibrosarcoma cells and regulates metastasis.

Authors:  Masuo Hanada; Kazuhiro Tanaka; Yoshihiro Matsumoto; Fumihiko Nakatani; Riku Sakimura; Tomoya Matsunobu; Xu Li; Takamitsu Okada; Tomoyuki Nakamura; Minoru Takasaki; Yukihide Iwamoto
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Vascular smooth muscle cell motility: From migration to invasion.

Authors:  Sherif F Louis; Peter Zahradka
Journal:  Exp Clin Cardiol       Date:  2010

4.  Tyrosine 397 phosphorylation is critical for FAK-promoted Rac1 activation and invasive properties in oral squamous cell carcinoma cells.

Authors:  Ya-Wen Chiu; Li-Yin Liou; Pin-Ting Chen; Chieh-Ming Huang; Fuh-Jinn Luo; Yu-Kan Hsu; Ta-Chun Yuan
Journal:  Lab Invest       Date:  2016-01-11       Impact factor: 5.662

Review 5.  The role of FAK in tumor metabolism and therapy.

Authors:  Jianliang Zhang; Steven N Hochwald
Journal:  Pharmacol Ther       Date:  2013-12-09       Impact factor: 12.310

6.  RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-κB pathway.

Authors:  Peifen Lu; Junjun Chen; Lihong Yan; Lijun Yang; Litao Zhang; Jie Dai; Zixuan Hao; Tao Bai; Yanfeng Xi; Yahui Li; Zhiming Kang; Jun Xv; Gongqin Sun; Tao Yang
Journal:  Cancer Biol Ther       Date:  2018-10-25       Impact factor: 4.742

Review 7.  Essentials of oral cancer.

Authors:  César Rivera
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

8.  SNAI1 expression and the mesenchymal phenotype: an immunohistochemical study performed on 46 cases of oral squamous cell carcinoma.

Authors:  Joerg Schwock; Grace Bradley; James C Ho; Bayardo Perez-Ordonez; David W Hedley; Jonathan C Irish; William R Geddie
Journal:  BMC Clin Pathol       Date:  2010-02-05

9.  Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis.

Authors:  Pawan Kumar; Arti Yadav; Samip N Patel; Mozaffarul Islam; Quintin Pan; Sofia D Merajver; Theodoros N Teknos
Journal:  Mol Cancer       Date:  2010-08-03       Impact factor: 27.401

10.  Molecular targets for tumour progression in gastrointestinal stromal tumours.

Authors:  N Koon; R Schneider-Stock; M Sarlomo-Rikala; J Lasota; M Smolkin; G Petroni; A Zaika; C Boltze; F Meyer; L Andersson; S Knuutila; M Miettinen; W El-Rifai
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.